Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC
- Citation:
- JTO Clin Res Rep vol 2 (8)
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- AFT
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub-ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 11
- Parents:
- 3081
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Merck
- Grants:
- Corr. Author:
- Authors:
- Thomas A. Hensing Xiaofei Wang Thomas E. Stinchcombe Junheng Gao Michael V. Knopp Mark Watson Arkadiusz Z. Dudek Stephen L. Graziano Jyoti D. Patel Bryan A. Faller Konstantin H. Dragnev David Kozono Everett E. Vokes
- Networks:
- HEARTLAND, IL018, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-NH012, LAPS-OH007, NY141
- Study
- AFT-09
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: